HexemBio emerges with a breakthrough blood stem cell rejuvenation technology led by Draper Associates and an advisory ...

With AI and massive profits at stake, Silicon Valley executives have shown that they are unwilling to mitigate its dangers.

Despite signing a deal potentially worth $2.1 billion, Vivtex Therapeutics CEO Thomas von Erlach, Ph.D., refuses to rest on ...

The internet is a bottomless pit information — whatever random thought pops into your head, there’s probably a fascinating ...

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk ...

What happened next may become the most important medical story of the decade. In just six months, a team at Children’s ...

Researchers have mapped how genetic switches are regulated in East Asian populations, identifying tens of thousands of unique ...

Since 2017, a personalized immunotherapy called Chimeric Antigen Receptor, or CAR-T cell treatment, has worked wonders to ...

Getting to Uranus had always been a fascination for many scientists. However, because of its immense distance from Earth, any ...

The cover of National Geographic’s March issue featured a tractor tire dangling from a thread. Not metaphorically, but ...

WARWICK, GB / ACCESS Newswire / April 7, 2026 / Moolec Science Limited, a wholly owned subsidiary of Moolec Science SA (NASDAQ:MLEC) ("the Company" "Moolec"), an innovation-driven company engineering ...

Evolution works over millennia. Climate change is moving far faster. That mismatch is killing some of the planet's most vital ...